The recent selloff in U.S. stocks continued this week, with the S&P 500 dropping by nearly 3% on Monday, and nearly an ...

OnKure's drug candidate pipeline is highlighted by OKI-219, a selective PI3K alpha H1047R inhibitor for the treatment of certain types of breast cancer that began clinical trials in February 2024.

Mesirow, an independent, employee-owned financial services firm, today announced that Wealth Advisor Jennifer Rosenblum, CFA ...

Smart buildings use advanced technologies to enhance energy efficiency, occupant comfort, and sustainability through ...